Intes Xavier, Ripoll Jorge, Chen Yu, Nioka Shoko, Yodh A G, Chance Britton
Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Med Phys. 2003 Jun;30(6):1039-47. doi: 10.1118/1.1573791.
We investigate the uptake of a nontargeted contrast agent by breast tumors using a continuous wave diffuse optical tomography apparatus. The instrument operates in the near-infrared spectral window and employs 16 sources and 16 detectors to collect light in parallel on the surface of the tumor-bearing breast (coronal geometry). In our protocol an extrinsic contrast agent, Indocyanine Green (ICG), was injected by bolus. Three clinical scenarios with three different pathologies were investigated. A two-compartment model was used to analyze the pharmacokinetics of ICG and preprocess the data, and diffuse optical tomography was used for imaging. Localization and delineation of the tumor was achieved in good agreement with a priori information. Moreover, different dynamical features were observed for differing pathologies. The malignant cases exhibited slower rate constants (uptake and outflow) compared to healthy tissue. These results provide further evidence that in vivo pharmacokinetics of ICG in breast tumors may be a useful diagnostic tool for differentiation of benign and malignant pathologies.
我们使用连续波扩散光学层析成像设备研究乳腺肿瘤对非靶向造影剂的摄取情况。该仪器在近红外光谱窗口工作,采用16个光源和16个探测器在荷瘤乳腺表面并行收集光(冠状几何结构)。在我们的实验方案中,通过推注注入一种外源性造影剂吲哚菁绿(ICG)。研究了三种不同病理情况的三种临床场景。使用双室模型分析ICG的药代动力学并对数据进行预处理,同时使用扩散光学层析成像进行成像。肿瘤的定位和轮廓勾勒与先验信息高度吻合。此外,不同病理情况呈现出不同的动力学特征。与健康组织相比,恶性病例的速率常数(摄取和流出)较慢。这些结果进一步证明,ICG在乳腺肿瘤中的体内药代动力学可能是鉴别良性和恶性病变的有用诊断工具。